Form 4: Nu-Med Plus Executive Receives Stock Grant
Insider Transaction (Form 4)
Fred Tejada, SVP and Chief Geologist, a Director and 10% owner of Nu-Med Plus, Inc., reported multiple transactions in common stock on July 8, 2026.
Summary
- Other acquisition/disposition: acquired 16,381,250 Common Stock on July 8, 2026; holds 16,381,250 after (Indirect).
- Grant/award: acquired 1,000,000 Series X Super Voting Preferred Stock on July 8, 2026; holds 1,000,000 after (Direct).
- Grant/award: acquired 129,782 Series A Preferred Stock on July 8, 2026; holds 129,782 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Fred Tejada — Director, Officer (SVP and Chief Geologist), 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-08 | Other acquisition/disposition | Common Stock | 16,381,250 | — | — | 16,381,250 |
| 2026-07-08 | Grant/award | Series X Super Voting Preferred Stock | 1,000,000 | — | — | 1,000,000 |
| 2026-07-08 | Grant/award | Series A Preferred Stock | 129,782 | — | — | 129,782 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-08 | Other acquisition/disposition (16,381,250 shares) |
| 2026-07-08 | Grant/award (1,000,000 shares) |
| 2026-07-08 | Grant/award (129,782 shares) |
Keywords
insider transaction, Form 4, NUMD, Nu-Med Plus, Inc., neutral, Fred Tejada
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.